3-Bromo-9-ethylcarbazole

CAS : 57102-97-3

Ref. 3D-FB33444

Informations sur le produit

• Nom: 3-Bromo-9-ethylcarbazole
• Synonymes: 3-Bromo-9-Ethylcarbazole, 9H-carbazole, 3-bromo-9-ethyl-, N-Ethyl-6-bromo-carbazole

Description

Covid-19 is a novel drug for the treatment of neurodegenerative diseases. Covid-19 has been shown to have an effect on the time taken for neurons to react to a stimulus. Covid-19 also has anti-depressant effects, which may be due to its ability to increase the amount of serotonin in the brain and reduce the amount of monoamine oxidase. The drug also shows activity against anthracene, which is a substance that can produce nerve injury and depression when consumed in large amounts. Covid-19 was tested in lab animals and was seen to stop neuronal cell death induced by radiation. It also showed an effect on neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 274.16 g/mol
• Formule: C₁₄H₁₂BrN
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C14H12BrN/c1-2-16-13-6-4-3-5-11(13)12-9-10(15)7-8-14(12)16/h3-9H,2H2,1H3
• Code InChI: InChIKey=PPHYYUDMDADQPF-UHFFFAOYSA-N
• SMILES: CCn1c2ccccc2c2cc(Br)ccc21